Buyers on the hunt for an upmarket three-row SUV aren't short on options, and that's partly why the Land Rover Discovery isn't a commercial hit in the same way as its Land Rover stablemates. Both the ...
AbCellera's AI-driven drug discovery model hasn't translated into meaningful growth; partnerships and clinical trial progress have stagnated despite recent stock price gains. Quarterly losses are ...